Ποια είναι η τιμή για BioSyntech, Inc. (BSYI)

Η τιμή για BioSyntech, Inc. (BSYI) είναι $0.00001

Ποια είναι η κεφαλαιοποίηση αγοράς για BioSyntech, Inc. (BSYI)

Η κεφαλαιοποίηση αγοράς για BioSyntech, Inc. (BSYI) είναι $229.03K

BioSyntech, Inc. (BSYI) Τιμή και Κεφαλαιοποίηση Αγοράς

BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels aimed at both repairing tissues and delivering therapeutic compounds. The company's key product pipeline features BST-CarGel, a biodegradable gel designed for cartilage repair; BST-InPod, intended for alleviating heel discomfort; BST-DermOn, for managing and healing chronic wounds; BST-Ossifil, used in bone void filling; BST-Ossifix, which provides structural support for bones; and BST-Disc, focused on restoring intervertebral discs. Beyond these, BioSyntech offers injectable products leveraging BST-Gel technology to precisely deliver biotherapeutics. Its technological assets also include Arthro-BST, an arthroscopic device for the non-destructive evaluation of cartilage degradation or repair, and Mach-1, a micromechanical testing system for assessing the properties of various tissues and materials. The company also manufactures ultra-pure chitosans under the Ultrasan brand and offers both manufacturing and analytical services. Founded in 1994 and based in Laval, Canada, BioSyntech Inc. initiated administration proceedings under the Bankruptcy and Insolvency Act on May 12, 2010, and is currently undergoing reorganization.

Η τιμή για BSYI	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$238.81 $229.03K	NVDA	$5.470T	+2,388,100,207.82%
$195.04 $229.03K	AAPL	$4.467T	+1,950,404,952.23%
$182.26 $229.03K	GOOG	$4.174T	+1,822,613,395.18%
$161.55 $229.03K	MSFT	$3.700T	+1,615,521,379.22%
$124.63 $229.03K	AMZN	$2.854T	+1,246,258,168.24%

Η τιμή για BSYI

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$238.81 $229.03K